IS5819A - Notkun á lífrænum estrógensúlfamötum í hormónaskiptameðferð - Google Patents

Notkun á lífrænum estrógensúlfamötum í hormónaskiptameðferð

Info

Publication number
IS5819A
IS5819A IS5819A IS5819A IS5819A IS 5819 A IS5819 A IS 5819A IS 5819 A IS5819 A IS 5819A IS 5819 A IS5819 A IS 5819A IS 5819 A IS5819 A IS 5819A
Authority
IS
Iceland
Prior art keywords
replacement therapy
hormone replacement
organic
estrogen sulfates
sulfates
Prior art date
Application number
IS5819A
Other languages
English (en)
Inventor
Walter Elger Dr.
Pekka Lähteenmäki DR.
Lehtinen Matti
Reddersen Gudrun
Holger Zimmermann DR.
Prof. Michael Oettel Dr.
PROF. Sigfrid Schwarz DR.
Original Assignee
Jenapharm Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh & Co. Kg filed Critical Jenapharm Gmbh & Co. Kg
Publication of IS5819A publication Critical patent/IS5819A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IS5819A 1998-07-28 2001-01-19 Notkun á lífrænum estrógensúlfamötum í hormónaskiptameðferð IS5819A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19834931A DE19834931A1 (de) 1998-07-28 1998-07-28 Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
PCT/DE1999/001496 WO2000006175A1 (de) 1998-07-28 1999-05-13 Verwendung von biogenen estrogenssulfamaten zur hormonsubstitutionstherapie

Publications (1)

Publication Number Publication Date
IS5819A true IS5819A (is) 2001-01-19

Family

ID=7876248

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5819A IS5819A (is) 1998-07-28 2001-01-19 Notkun á lífrænum estrógensúlfamötum í hormónaskiptameðferð

Country Status (28)

Country Link
US (1) US7053077B1 (is)
EP (1) EP1100509B1 (is)
JP (1) JP4891479B2 (is)
KR (1) KR20010072082A (is)
CN (1) CN1311683A (is)
AP (1) AP2001002054A0 (is)
AR (1) AR016502A1 (is)
AT (1) ATE292468T1 (is)
AU (1) AU766019B2 (is)
BG (1) BG105171A (is)
BR (1) BR9912466A (is)
CA (1) CA2338558A1 (is)
CO (1) CO5261567A1 (is)
DE (2) DE19834931A1 (is)
EA (1) EA003371B1 (is)
EE (1) EE200100053A (is)
HK (1) HK1040192A1 (is)
HU (1) HUP0102913A3 (is)
IL (1) IL141081A0 (is)
IS (1) IS5819A (is)
MX (1) MXPA01000548A (is)
NO (1) NO20010468L (is)
NZ (1) NZ509521A (is)
PL (1) PL345588A1 (is)
SK (1) SK1292001A3 (is)
TR (1) TR200100234T2 (is)
WO (1) WO2000006175A1 (is)
ZA (1) ZA200100743B (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006027A1 (en) 2001-07-13 2003-01-23 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
US8282612B1 (en) 2008-03-07 2012-10-09 Denise H. Miller Methods and devices for intrauterine absorption
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
EP2647379A1 (en) * 2012-04-05 2013-10-09 PregLem S.A. Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9078786B1 (en) 2012-10-19 2015-07-14 Denise H. Miller Methods and devices for collecting body fluids
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN116392450B (zh) * 2022-09-07 2025-07-01 江苏集萃新型药物制剂技术研究所有限公司 含雌激素的皮下植入物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314694A (en) * 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
EP0708636A1 (en) * 1993-06-29 1996-05-01 Leiras Oy Pack for use in, and method of hormonal replacement therapy
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4447715C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Behandlung von Prostatakarzinomen
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19610635A1 (de) * 1996-03-11 1997-09-18 Schering Ag Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
TW448049B (en) * 1997-03-05 2001-08-01 Akzo Nobel Nv Use of a 7Α-methyl-17Α-ethynyl-estrane derivative for the treatment of atherosclerosis
AU4957999A (en) * 1998-07-17 2000-02-07 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for contraception

Also Published As

Publication number Publication date
WO2000006175A1 (de) 2000-02-10
HUP0102913A3 (en) 2002-03-28
EE200100053A (et) 2002-06-17
BG105171A (bg) 2001-07-31
NZ509521A (en) 2003-11-28
HUP0102913A2 (hu) 2002-01-28
JP4891479B2 (ja) 2012-03-07
AP2001002054A0 (en) 2001-03-31
CA2338558A1 (en) 2000-02-10
AU766019B2 (en) 2003-10-09
EA200100108A1 (ru) 2001-12-24
BR9912466A (pt) 2001-04-17
TR200100234T2 (tr) 2001-06-21
NO20010468L (no) 2001-03-27
SK1292001A3 (en) 2001-07-10
KR20010072082A (ko) 2001-07-31
DE59911879D1 (de) 2005-05-12
NO20010468D0 (no) 2001-01-26
PL345588A1 (en) 2001-12-17
AU5148199A (en) 2000-02-21
EP1100509B1 (de) 2005-04-06
ATE292468T1 (de) 2005-04-15
CN1311683A (zh) 2001-09-05
EP1100509A1 (de) 2001-05-23
MXPA01000548A (es) 2002-04-08
JP2002521452A (ja) 2002-07-16
CO5261567A1 (es) 2003-03-31
IL141081A0 (en) 2002-02-10
US7053077B1 (en) 2006-05-30
EA003371B1 (ru) 2003-04-24
HK1040192A1 (zh) 2002-05-31
AR016502A1 (es) 2001-07-04
ZA200100743B (en) 2002-05-08
DE19834931A1 (de) 2000-02-24

Similar Documents

Publication Publication Date Title
IS5819A (is) Notkun á lífrænum estrógensúlfamötum í hormónaskiptameðferð
ATE251130T1 (de) Neue 3-aryl-propionsäurederivate und analoge
ID19543A (id) Terapi penggantian hormon total
AU5003401A (en) Hormone replacement therapy
IS5760A (is) Meðferðarlegar bíarýl afleiður
IS5921A (is) Staðgengnar Bensópýrahliðstæður til notkunar við meðhöndlun á bólgu
DE69942359D1 (de) Beleuchtungsschirm in tandemanordnung
NO20015314L (no) Steroidderivater
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
FI20020071A7 (fi) Applikaattori kõytettõvõksi refleksoterapiassa
DE69932650D1 (de) Zementierkopf
NO20021400D0 (no) Terapeutiske konazolinderivater
EP1015578A4 (en) THERAPEUTIC MOLECULES
DE69815619D1 (de) Vorschaltgerät
DE60008799D1 (de) Stromversorgungshilfsaggregat und dessen betriebsverfahren
FI20020072A7 (fi) Applikaattori kõytettõvõksi refleksoterapiassa
IS5025A (is) Samtengd efnasambönd nytsamleg við meðhöndlunina á krabbameini í blöðruhálskirtli
NO20034097D0 (no) Hormonerstatningsterapi
ID15967A (id) Agen terapi diabetes
IS5502A (is) Samtengd efnasambönd nytsamleg við meðhöndlun á krabbameini í blöðruhálskirtli
DE59808490D1 (de) Penisextensionsgerät
DE59901471D1 (de) Schaltnetzteil
DE69800385D1 (de) Taktversorgungsgerät
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
IS5814A (is) Ný lyfjafræðileg notkun á NOS lötum